KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹7.04 Cr | ₹-14 Cr | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹7.04 Cr |
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-17 Cr |
| Mar2023 | ₹0.99 Cr |
| Mar2022 | ₹5.66 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.04 Cr | Positive | |
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-17 Cr | Negative | |
| Mar2023 | ₹0.99 Cr | -82.43 | |
| Mar2022 | ₹5.66 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,774.8 Cr | 4.4% | 7.6% | 276.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 4.4% |
7.6% |
276.5% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses